News from the healthcare data industry
Research developed using Verana Health’s Ophthalmology Qdata™, quality real-world data stemming from the American Academy of Ophthalmology IRIS® Registry SAN FRANCISCO, July 18, 2022 /PRNewswire/ — Verana Health®—a digital health data company elevating...
July 2, 2022 Rose McNulty Real-world patients often differ from those eligible for clinical trials, and comparing results in both populations is a key step in fine-tuning treatment strategies for...
A growing — and aging — population, combined with advances in early detection and treatment, pushed the number of cancer survivors to new heights this year. More than 18 million...
NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced overall survival (OS) results from the Phase 3 PALOMA-2 trial, which evaluated IBRANCE® (palbociclib) in combination with letrozole compared to placebo plus...
COBALT study in advanced PBC, previously terminated early due to feasibility challenges, did not demonstrate a statistically significant difference in clinical endpoints between Ocaliva® and placebo HEROES-US real-world analysis demonstrated statistically...
Real-world results may differ from clinical trial results for some drugs approved to treat gastrointestinal cancers, according to research published in Clinical Oncology. Researchers found that EGFR inhibitors and sorafenib performed...
SAN FRANCISCO, May 27, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new...
May 26, 2022 05:30 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced three Flatiron-authored abstracts have been accepted for poster discussion and presentations at the 2022 American Society of Clinical...
Key data reinforce the utility of Foundation Medicine’s tissue- and blood-based comprehensive genomic profiling to support treatment planning, and demonstrate the value of real-world genomic data to facilitate equitable research...
ABSTRACT PURPOSE: In an era of rapid expansion of FDA approvals for oral anticancer agents (OAAs), it is important to understand the factors associated with survival among real-world populations, which...